Page 13 - Test PDF v5
P. 13
« Back to Contents OVARIAN CANCER
LiFE re
Literature for ENYGO
Pathology/pathogenesis of malignant ovarian tumours
Relevant articles retrieved Nov 2015 - Feb 2016
No Title Authors Journal Link to abstract
PLOS One. http://dx.doi.org/10.1371/journal.
1 L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Hong H et al. pone.0146885
Human T Cells Exhibit Specific and Efficient Antitumor Activity against Nat Med.
Human Ovarian Cancer in Mice. Oncotarget. http://dx.doi.org/10.1038/nm.4032
2 Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor Du Y et al. Cancer Res. http://dx.doi.org/10.18632/oncotar-
effects of PARP inhibitors. Gynecol Oncol. get.7277
J Pathol.
3 Association and prognostic significance of BRCA1/2-mutation status with Strickland KC et al. J Pathol. http://dx.doi.org/10.1158/0008-
neoantigen load, number of tumor-infiltrating lymphocytes and expression of 5472.CAN-15-1382
PD-1/PD-L1 in high grade serous ovarian cancer. http://dx.doi.org/10.1016/j.ygy-
no.2015.09.083
4 It's Totally Tubular….Riding The New Wave of Ovarian Cancer Research. Perets R et al. http://dx.doi.org/10.1002/path.4657
5 Emerging strategies for targeting PI3K in gynecologic cancer. Bregar AJ et al. http://dx.doi.org/10.1002/path.4663
6 Models of endometriosis and their utility in studying progression to ovarian King CM et al.
clear cell carcinoma. Morin PJ et al.
7 Genetically-defined ovarian cancer mouse models.
International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 13
